Cytokinetics Inc

Common Name
Cytokinetics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
498
Ticker
CYTK
Exchange
NASDAQ/NGS
Description
Cytokinetics, Incorporated is a biopharmaceutical company specializing in the discovery, development, and commercialization of innovative muscle activators and inhibitors. Its primary mission is to ad...

Cytokinetics Waste Data Preview

In 2023, Cytokinetics conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2024202320222021 - 2017
Total Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Waste Recovered
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Non-Hazardous Waste Disposed
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.

Insights into Cytokinetics's Waste Treatment Practices

In 2023, Cytokinetics generated a total of 106 metric tonnes of waste.

Of this amount, 60.51% of Cytokinetics's total waste generated was recovered through methods such as recycling, reuse, or composting, while 39.49% was disposed of through landfilling, incineration, or combustion.

Cytokinetics's Waste Recovery Rate

61%

How much of Cytokinetics's waste is recycled or recovered?

In 2023, Cytokinetics reported a total waste generation of 106 metric tonnes, of which 60.51% was recovered through recycling, reuse, or composting. This moderate level of recovery indicates that Cytokinetics is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.

Insights into Cytokinetics’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Cytokinetics generated a total of 106 metric tonnes of waste.

Of this amount, 17.33% of Cytokinetics's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 82.67% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.

How does Cytokinetics treat its hazardous waste?

In 2023, Cytokinetics reported that 18 metric tonnes of its total waste output were classified as hazardous. This represents 17.33% of its overall waste generation.

The company treated this hazardous waste using a combination of methods. Approximately 19.44% was managed through recovery methods, indicating a moderate integration of circular practices into its hazardous waste management. However, a significant share was still directed toward disposal, highlighting room for improvement in reducing the long-term impact of hazardous materials.

Breakdown of Cytokinetics's Hazardous and Non-Hazardous Waste by Treatment Method

Hazardous WasteDisposed(14.0%)Non-Hazardous WasteDisposed(25.5%)Non-Hazardous WasteRecovered(57.1%)
Want Full Access to Cytokinetics's Waste Management Dataset?
Sign Up